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Abstract
Background: Mozambique has high maternal mortality which is compounded by limited human resources for
health, weak access to health services, and poor development indicators. In 2011, the Mozambique Ministry of
Health (MoH) approved the distribution of misoprostol for the prevention of post-partum haemorrhage (PPH) at
home births where oxytocin is not available. Misoprostol can be administered by a traditional birth attendant or
self-administered. The objective of this paper is to examine, through applying a human rights lens, the broader
contextual, policy and institutional issues that have influenced and impacted the early implementation of
misoprostol for the prevention of PPH. We explore the utility of rights-based framework to inform this particular
program, with implications for sexual and reproductive health programs more broadly.
Methods: A human rights, health and development framework was used to analyse the early expansion phase of
the scale-up of Mozambique’s misoprostol program in two provinces. A policy document review was undertaken to
contextualize the human rights, health and development setting in Mozambique. Qualitative primary data from a
program evaluation of misoprostol for the prevention of PPH was then analysed using a human rights lens; these
results are presented alongside three examples where rights are constrained.
Results: Structural and institutional challenges exacerbated gaps in the misoprostol program, and sexual and
reproductive health more generally. While enshrined in the constitution and within health policy documents,
human rights were not fully met and many individuals in the study were unaware of their rights. Lack of
information about the purpose of misoprostol and how to access the medication contributed to power imbalances
between the state, health care workers and beneficiaries. The accessibility of misoprostol was further limited due to
dynamics of power and control.
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Conclusions: Applying a rights-based approach to the Mozambican misoprostol program is helpful in
contextualising and informing the practical changes needed to improve access to misoprostol as an essential
medicine, and in turn, preventing PPH. This study adds to the evidence of the interconnection between human
rights, health and development and the importance of integrating the concepts to ensure women’s rights are
prioritized within health service delivery.
Keywords: Post-partum haemorrhage, Maternal health, Human rights, Development, Mozambique, Right to health
Background
In 2015, approximately 303,000 women worldwide died
during pregnancy and/or due to childbirth complications
and almost all in low to middle income countries [1]. The
main causes were post-partum haemorrhage (PPH), sepsis,
pre-eclampsia or eclampsia, complications arising at the
time of birth and unsafe abortion. All of these causes are, to
a large extent, preventable [1]. PPH alone accounts for
nearly one quarter of all maternal deaths worldwide [2].
Oxytocin (administered intravenously or intramuscu-
larly) is recommended for the prevention of PPH, but
when oxytocin is not available, misoprostol, a medication
available in tablet form (600 mcg oral) can be used as an
alternative [3]. Oxytocin is rarely accessible to women giv-
ing birth outside a health care setting due to the need for
refrigeration and administration via injection [4, 5]. Oxy-
tocin is widely used in health facilities across Mozambique
but 30% of births take place without a skilled birth attend-
ant (SBA) and therefore many women give birth without
uterotonic protection (IMASIDA, [6]).
Misoprostol is a safe alternative for the prevention of PPH
when administered immediately after the birth where oxyto-
cin is not available [3]. Misoprostol is available internationally
in 200mcg tablets. Therapeutic or preventive doses for PPH
are usually administered as 3 tablets (600mcg) or 4 tablets
(800 mcg) [3]. Misoprostol can be self-administered or ad-
ministered by a trained community health worker (CHW) or
traditional birth attendant (TBA) [7, 8].
Mozambique has a population of 28.9 million with an
average life expectancy of 55.1 years [9, 10]. In 2015,
Mozambique’s maternal mortality ratio was estimated at
489 per 100,000 live births [11]. Haemorrhage, both
antepartum and post-partum, is a leading cause of ma-
ternal deaths [12–14].
In 2009–2010, the Ministry of Health (MoH) commis-
sioned a study to assess the effectiveness and feasibility
of distributing misoprostol for the prevention of PPH in
the community. The study showed that distribution
through both TBAs and antenatal care (ANC) achieved
99% misoprostol use among women who gave birth un-
assisted at home [15]. Subsequently, the results sup-
ported the MoH to plan for the distribution of
misoprostol for PPH prevention at the community level
via ANC and TBAs.
In 2015, the National Strategy for the Prevention of
PPH at the Community Level (referred to as the
National Strategy for PPH) was launched by the MoH
and partners. The strategy outlined a plan to roll-out the
misoprostol program in 35 of 128 districts across the
country. Since then, the MoH and a number of MNCH
partners have contributed technical support for the im-
plementation of the misoprostol program including
Jhpiego’s Maternal and Child Survival Program (MCSP)
and the United Nations Population Fund (UNFPA).
Human rights and gender equality are well enshrined
in legal frameworks in Mozambique, including the first
Constitution in 1975 [16]. Mozambique is signatory to
most major human rights treaties aimed at promoting
equal rights for women and men (See Additional file 1).
However, in practice a number of barriers prevent
women from accessing their rights, including access to
misoprostol.
Human rights based approaches can be used to ensure
rights are embedded into a program or policy from the
onset and incorporated into each step of the program
cycle including policy, planning, implementation and
monitoring and evaluation [17]. The essential compo-
nents of a human rights approach include: universality
with a focus on vulnerable populations; indivisibility/
interdependence; accountability; participation; rule of
law; and progressive realization, access, affordability,
quality [18, 19].
Health, human rights and development interface in a
simple framework (Fig. 1) designed by Tarantola et al.
[20, 21] that can be used to analyse a state’s capacity to
uphold human rights, provide essential health services
and encourage human development. The framework
goes beyond the usual programmatic challenges by for-
cing more in-depth, nuanced understanding of relevant
systems [20, 21].
This paper applies a rights-based framework to under-
standing the broader contextual, policy and institutional
issues at play in the early implementation of misoprostol
for the prevention of PPH. We then explore the utility
of a rights-based framework to inform the Mozambique
misoprostol program as a unique case study, and con-
sider the implications for sexual and reproductive health
programs more broadly.
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Methods
This paper presents an analysis of the early expansion
phase of the scale-up of Mozambique’s misoprostol pro-
gram in two provinces through the lens of a Tarantola
and colleagues’ human rights, health and development
framework [20, 21] (see Fig. 1). This qualitative study had
two main components. The first was a policy document
review to describe the human rights, health, and develop-
ment context in Mozambique. The second was a thematic
analysis of qualitative primary data from a program evalu-
ation of misoprostol for the prevention of PPH. The
health, human rights and development framework was
used to identify three examples from the primary data
which describes where rights might have been infringed.
Policy document review
A document review of misoprostol program and policy
documentation in Mozambique was undertaken with the
goal of identifying the key documents most salient to health
and reproductive rights. These documents were initially
accessed through a grey literature search online, using a
combination of key words in English and Portuguese in-
cluding “health”, “development” AND/OR “human rights”
in “Mozambique”. We then triangulated our grey literature
search with the MoH and program partners through the
course of the study. Core documents included the National
PPH Strategy; The National Health Sector Strategic Plan
2015–2019; the National Plan for Health and Human Re-
source Development; Demographic and Health Surveys
(2011 & 2015); the international human rights treaties
Mozambique has signed and ratified; the UNDP Human
Development Index; and gender equity publications and
policy areas related to health and development at the na-
tional, regional and organisational levels. Forward snowbal-
ling of references and suggestions from the MoH and
program partners were used to locate additional documents
and literature. A thematic analysis of the documents was
undertaken under the Framework’s central tenents of hu-
man rights, health and development [20].
Analysis of qualitative primary data
Qualitative data from semi-structured interviews and
focus group discussions were collected in 2017 as part of a
larger evaluation of the scale-up of misoprostol for the
prevention of PPH in two provinces in Mozambique [22].
The broader study aimed to a) uderstand TBA’s roles and
perceptions on the distribution of misoprostol; b) explore
the views of women who had used misoprostol; c) identify
facilitators and barriers to the early expansion of the miso-
prostol program for the prevention of PPH at the commu-
nity level; and d) examine coverage and utilisation of
misoprostol in the two provinces.
Study interview guides for stakeholders and health staff
were developed using existing tools relevant to this study
[23, 24]. Questions focussed on the process of scale-up in-
cluding barriers and enablers; dissemination and advocacy;
organizational inputs; finances/mobilization of resources;
and monitoring and evaluation. CHWs and TBAs were
interviewed about their use and understanding of misopros-
tol and the barriers and enablers to the misoprostol pro-
gram. Women who used misoprostol were asked questions
about their experience receiving and using the medication.
Purposive sampling was used to select the research
participants based on consultation with key stakeholders
in the program, assistance from district health staff,
community health workers, and women who used miso-
prostol. MNCH stakeholders were interviewed based on
their involvement in the misoprostol program. Details of
recruitment and data collection procedures are docu-
mented elsewhere [22, 25].
In total, focus group discussions and semi-structured
key informant interviews were undertaken with:
i. 15 Ministry of Health staff and policy/MNCH
stakeholders.
ii. 19 health staff involved in the misoprostol program
(Medical directors, hospital directors, MNCH
nurses, midwives, health technicians/auxiliary staff
and pharmacists).
iii. 15 community health workers and coordinators, 15
traditional birth attendants (TBAs) and 11 women
who had used misoprostol.
iv. 4 focus groups discussions (FGDs) with TBAs in
Nampula Province.
Most interviews and FGDs were conducted in local
language or where appropriate, Portuguese. Interviews
averaged 45min and were recorded with participant per-
mission. MNCH stakeholder interviews took place in
Maputo city, Inhambane and Nampula Provinces at the
participant’s office or convenient alternative. Team
members debriefed daily to record observations and
context. Recruitment and data collection procedures are
elaborated elsewhere [22, 25].
Fig. 1 The Health, Human Rights and Development Triangle
(Originally printed in Tarantola et al., 2008 [20] with permission
obtained to re-print. This figure has been republished in Tarantola
et al., 2013 [21])
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Two international and three local research assistants
collected data. Research assistants received training on
qualitative data collection and research ethics. Inter-
views, field notes and recordings were translated and
transcribed in Portuguese by Mozambicans who spoke
local dialects, and then translated into English. Data
quality checks from Portuguese to English were under-
taken by KH and JH by listening to the interview record-
ing in Portuguese alongside the Portuguese transcripts
and English translation. Nvivo (v.11) software was used
to undertake the analysis. The first author read all inter-
views and documents twice to become familiar with the
data. All data were deductively coded by the first author
according to the underpinning constructs of the frame-
work [20]. The second round of coding was inductive
and resulted in the emergence of additional themes. The
analysis was cross-checked with co-authors to ensure in-
terpretation of meaning was accurate.
Ethical clearance was obtained from the Human Re-
search Ethics Committee at Charles Darwin University,
Australia (HREC 2015–2445) and the Mozambican Na-
tional Bioethics Committee and MoH (105/CNBS/2016).
All participants were informed of the study purpose, po-
tential risks and benefits, after which written informed
consent was obtained. All participants were given the
right to refuse or withdraw at any point; none did so.
Results
We first present the broad health and policy context in
Mozambique that emerged from the policy document
analysis. An overview of the misoprostol program fol-
lows from both primary and secondary data sources. Fi-
nally, three case studies, or situations, were chosen from
the qualitative data to highlight how a rights-based ap-
proach could assist women, TBAs and health staff to ac-
cess their rights and improve program delivery.
All data were deductively coded into the three categor-
ies of the framework; human rights, health or develop-
ment. A second round of coding was undertaken in each
category resulting in additional themes. Themes that
emerged within the human rights category included, UN
Conventions, Mozambican women’s rights; access to in-
formation; punitive/threatening behaviour; and abortion.
Under the health category, themes included access and
quality of maternal health care; pressure to increase
health facility deliveries; and health systems. Themes in
the development category included economic situation;
Sustainable Development Goals; gender equity; distance
and infrastructure.
Human rights, health, and development context
Human rights
The human rights domain reflects the international, re-
gional and national laws and policies that pertain to a
state’s legal system. The results presented here include
UN conventions that have been ratified and endorsed,
the status of Mozambican women’s rights, abortion laws,
access to sexual and reproductive health (SRH) informa-
tion, and limitations on the distribution of misoprostol
due to the eligibility criteria within the program.
Mozambique is a signatory to major international hu-
man rights conventions which recognize the human
right to health. For example, Article 12 of the Conven-
tion on the Elimination of All Forms of Discrimination
Against Women (CEDAW) makes specific mention of
reproductive health rights; states have the responsibility
to ensure that men and women have access to health
services including family planning and women receive
free pregnancy, post-natal, labour and birth services, and
information to decide on birth spacing [26]. Other hu-
man rights instruments to which Mozambique is signa-
tory can further advance reproductive and sexual health
(See Table 1 in Additional file 1). Mozambique is not
party to the International Covenant on Economic, Social
and Cultural Rights (ICESCR) which contains Article 12
and General Comment 14, the right to the highest at-
tainable standard of health [29]. State authorities have
cited a lack of resources to uphold the rights within the
ICESCR as the predominant reason for abstaining from
signing the covenant [30].
Table 1 Maternal and child health indicators in Mozambique
Indicator Source, Reference
Maternal Mortality Ratio 489/100000 (World Health Organization, 2015) [11]
% Births attended by a Skilled Birth Attendant 70 (91% urban; 67% rural) (IMASIDA, 2016) [6]
Lifetime Risk of Maternal Mortality 1/40 (World Health Organization, 2015) [11]
Neonatal Mortality Rate 27.1/1000 live births (World Health Organization, 2016) [27]
Fertility Rate (ages 15–49; 2015) 5.9 (6.6 rural; 4.5 urban) (IMASIDA, 2016) [6]
Demand for family planning for 15–49 year olds 50% (47% rural; 57% urban) (IMASIDA, 2016) [6]
Access to contraception for 15–19 year olds 14.1% (Family Planning 2020, 2017) [28]
% of women > 25 with some secondary education in 2015 2.8% (IMASIDA, 2016) [6]
% of men with some secondary education in 2015 8% (IMASIDA, 2016) [6]
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The Mozambican government, including the MoH, re-
fers to the human right to health within key national
documents including the National Health Sector Strat-
egy 2014–2019 which states;
The vision, mission and guiding principles […] were
developed based on the premise that health consti-
tutes a basic human right, as such, they reflect the
long-term values and aspirations of Mozambicans.
This approach aims to substantiate the right to
health and other related human rights reflected in
the country’s legal framework [31].
Access to contraception and the ability to negotiate
contraceptive use and plan pregnancies are reproductive
health rights as stated in Article 12 of CEDAW [26]. In-
creasing access to sexual and reproductive health ser-
vices, especially modern contraception, is a main
objective in the 2014–2019 Health Sector Strategy [31].
In 2014, the abortion laws in Mozambique were re-
formed, which increased legal access to safe abortion
[32]. Women could now access a safe abortion up to 12,
16 or 24 weeks depending on their circumstances [32].
All abortions must be provided in a health facility with a
qualified health professional. Parental consent must be
obtained for girls under 16 years of age or those with
mental illness [33]. In 2016–2017, the Ministry of Health
and partner organizations developed clinical guidelines
for abortion and post-abortion care [33]. At the time of
data collection, abortion remained accessible only at
some tertiary and quaternary hospitals and was difficult
to access in rural areas [34].
Health
The health domain includes an analysis of key health
and health system indicators. This section examines
Mozambique’s maternal health indicators, human re-
sources for health, and health supplies as a measure of
the country’s progress in upholding the right to health
(See Table 1). Maternal health is a good indicator of
women’s status in terms of health, development and hu-
man rights. Health and development are directly con-
nected; enjoyment of the right to health is a prerequisite
for, as well as an outcome of, development [21].
High maternal mortality and morbidity persist in
Mozambique. Between 1990 and 2013, the country experi-
enced a 64% reduction in maternal mortality [35]. Despite
this, Mozambique did not meet Millennium Development
Goal (MDG) 5 to reduce the maternal mortality ratio
(MMR) to 330 per 1,000,000 [36]; the MMR remains ex-
tremely high (489/100000 live births) [11]. The lifetime
risk of maternal death remains high; one in 40 Mozambi-
can women will die during childbirth [11].
Mozambique has a high fertility rate (5.9), and limited
access to family planning. Nampula Province has a higher
fertility rate at 6.1 versus Inhambane Province at 4.9
(IMASIDA, [6]). In 2017, only 14.1% of youth between the
ages of 15–19 had access to contraception [28]. Abortion
is a leading direct cause of maternal mortality in
Mozambique [31]. The 2011 Demographic Health Survey
(DHS) revealed that 9% of women aged 15–49 years re-
ported that they had ever terminated a pregnancy [37].
The MoH identified the reduction of maternal and
neonatal mortality as the first of five key national health
priorities outlined in the National Health Sector Strategy
2014–2019. One of the main objectives to reach this tar-
get was to expand and improve health services. The sec-
ond strategic goal under this objective was related to
misoprostol; ‘…and introducing and expanding the use
of Misoprostol at HF [Health Facility] and community
level for the prevention and control of post-partum
haemorrhage’ [31].
Health services
Maternal health services in Mozambique are well described
elsewhere [31]. The country has made significant strides in
increasing the number of qualified health staff since the
end of the civil war [38]. However, the ratio of qualified
heath providers to patients remain insufficient; in 2013
there were 0.05 physicians and 0.40 nurses and midwives
per 1000 population [27]. There are vast disparities between
rural and urban populations in terms of access to repro-
ductive health services, quality of care, transport and infra-
structure. Rural women have less access to health services
and skilled birth attendants (67% rural versus 91% urban)
than those living in urban locations [6].
Essential medicines in Mozambique are distributed
through the Centre for Medicines and Drug Supplies in
Maputo and a regional warehouse located in Beira, Sofala
Province. Medications are sent to 10 provincial ware-
houses and central hospitals across the country and sent
to the district level warehouse for distribution to health fa-
cilities. The MoH supply chain experiences weaknesses in
distribution from district to health facility level. Between
2011 and 2013, 85% of 13 district warehouses in Sofala
Province experienced a stock-out of an essential drug and
all had a stock-out of an essential product at least once in
the three annual stock assessments [39]. Medicine stock-
outs at the health facility level are most strongly associated
with distance from the district warehouse [39]. In 2015, a
UNFPA assessment found that 84% of health facilities
across Mozambique had at least seven essential maternal
and reproductive health medicines, an improvement from
previous years (59% in 2014) [40].
Only half of rural health facilities have electricity or
solar power systems and 60% have a water supply [31].
In 2015, 11% of Mozambican health facilities lacked
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access to a cold chain to conserve medical supplies, in-
cluding oxytocin [40]. Poor infrastructure, lack of trans-
portation, limited numbers of health facilities, and
quality of services all impact access to rural health ser-
vices in Mozambique [41, 42].
Development
The development domain examines the processes and
goals of human development which improve people’s
opportunities and ultimately their lives [21]. Develop-
ment was recognized as a right in 1986. Several develop-
ment issues facilitated the expansion of the misoprostol
program and the health and human rights of women.
Those included Mozambique’s key economic indicators,
progress on Sustainable Development Goals (SDGs),
gender equity, literacy rates and access to education.
In 2015, Mozambique ranked 182 out of 187 countries
in the UNDP Human Development Index, making it one
of the least developed countries in the world [43]. Gross
National Income per capita is $1098 [43]. Overall,
Mozambique ranked 29 of 51 countries in the 2018
African SDG report (The SDG Center for Africa and Sus-
tainable Development Solutions Network, 44). The coun-
try is experiencing serious challenges attaining nine of
seventeen SDGs, including poverty, hunger, health and
well-being, education, gender equality, water and sanita-
tion and innovation, industry and infrastructure [44]. The
country ranks particularly low in the first Goal to end pov-
erty, with 66.6% of the population living on less than 1.90
USD per day, and the second Goal to end hunger, with
26.6% of the population undernourished and 41.2% stunt-
ing among children under the age of five [44]. While the
net primary school enrolment is high at 89.6%, on average
children spend only 3.5 years in school.
Health financing directly impacted progress of the mi-
soprostol program. In 2017, the health sector received
US$ 300.1 million which was 7.8% of the total value of
the State Budget [45]. State funding for general health
operations and human resources was largely seen as be-
ing insufficient. The budget for the misoprostol program
was largely dependent on external donor funding and
was not fully realised. This impacted the program as
monitoring and evaluation including supervisory visits
was largely unfunded.
In 2017, Mozambique ranked 139 out of 159 countries
in the Gender Inequality Index [46] with particularly poor
ranking in reproductive health and access to education.
The Global Gender Gap report ranked Mozambique 130
of 144 countries in terms of women’s educational attain-
ment. Women have a lower literacy rate than men (36.5%
versus 67.4%) and lower enrolment at primary, secondary
and tertiary schools [47]. Only 2.8% of women over the
age of 25 had some secondary education versus 8% of
men (IMASIDA, [6]). Female representation in parliament
was fairly high (39.6%) as was involvement in the work-
place (82.5%) [43].
Although women have high participation in the labour
market, they predominately work in poorly paid work in-
cluding subsistence farming and domestic labour and
often do not have rights to the land they farm or the in-
come they earn [48, 49]. Women earn 80% of the wage
that a man does for the same work [50]. The application
of gender policy and women’s rights is weak given the
dominant patriarchal socio-cultural order, limited imple-
mentation and a passive judiciary [16, 51].
Misoprostol program
The National PPH Strategy outlines the misoprostol pro-
gram to reduce the incidence of PPH with a plan for
universal distribution to women [14]. In 2015, the pro-
gram was initiated in 6 districts in Sofala and Inhambane
Provinces. The intention was to learn from these sites
and adapt the program as necessary in the remaining 29
districts [52].
As of 2017, misoprostol for the prevention of PPH has
been introduced in 35 districts and is led by the MoH at
Central, Provincial and District levels [22] Misoprostol is
on the Essential Medicines List (EML), and is distributed
via the MoH pharmaceutical system. UNFPA funds the
procurement of misoprostol and initial training of health
staff, CHWs and TBAs. Jhpiego’s MCSP Program funded
training and the provision of technical support in two
provinces. The MoH depends on external funding for
the program and the 2.6 million USD budget for the mi-
soprostol program was not fully funded [22] See Fig. 2
for a historical overview of the program.
MNCH nurses and midwives were trained to distribute
misoprostol to women in advance at antenatal care ap-
pointments after 28 weeks gestation. However, not all
MNCH staff received training; approximately a quarter
of the MNCH nurses interviewed said they had not re-
ceived formal training in the program. Some MNCH
nurses reported some discomfort distributing the medi-
cation which was a barrier to implementation [22].
Other health staff, including pharmacists, did not receive
training. Interviews revealed that there was limited dis-
semination of the National PPH Strategy, particularly at
the district level and many pharmacists were unaware of
the strategy. TBAs were trained to distribute misoprostol
directly to the woman after she gave birth and before
the placenta was born. TBAs received the dose of miso-
prostol (3 pills) from their local CHW.
In 2015, soon after the program began, the MoH in-
troduced selection criteria to increase controls to reduce
the risk of misuse for abortion and limit the amount of
misoprostol in the community. The criteria outlined
which women can qualify for advanced distribution of
misoprostol at the health facility. The criteria stated that
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a pregnant woman must be registered for antenatal care
where misoprostol is available and have reached 28
weeks gestation. She must additionally meet at least one
of the following criteria: 1) a history of giving birth at
home/outside of the health facility; 2) reside more than
8 km from a health facility; 3) be a grand multipara
(more than 5 previous births); 4) a current or past his-
tory of multiple pregnancies; 5) a history of postpartum
haemorrhage.
Disparities were found between the two provinces in
terms of access and utilisation of misoprostol. Nampula
Province reported very high coverage whereas Inhambane
reported lower coverage. Higher coverage in Nampula was
possibly due to encouragement from political champions,
support from Jhpiego’s MCSP program and previous
knowledge of the benefits of misoprostol due to the 2009–
2010 pilot study that took place in the Province. Inter-
views in Inhambane found that low coverage was in part
due to the strong priority health staff placed on applying
the selection criteria, medical directors and pharmacist’s
perceptions that misoprostol may be misused for abortion
or used incorrectly and the emphasis of the MoH on en-
couraging facility births. Further details of the access and
utilisation are presented elsewhere [22].
The MoH leads the misoprostol program and has begun
to institutionalise it within the health system in the 35 tar-
get districts. However, our previous study found a number
of barriers surrounding coverage due to the adaptation
from universal to select distribution; fear of misdirecting
misoprostol for abortion or labour induction; limited dis-
semination of the National Prevention of PPH Strategy;
insufficient monitoring and evaluation; challenges with
the logistics system and an inability to engage remote
Traditional Birth Attendants [22]. Stakeholders from a
number of districts reported shortages of misoprostol
stock, despite submitting requests to the provincial phar-
macy. The lack of a regular supply of stock appeared to be
a major reason for low coverage in Inhambane Province.
Although the program was led by the MoH, it is currently
taking place in only 35 of 128 districts and some health
staff questioned the sustainability of the program.
The infringement of rights: three examples
This section of the paper presents three examples derived
from the analysis of primary data to illustrate where rights
were infringed. The first example describes women’s expe-
riences of discrimination for not giving birth in a health
facility. The second example surrounds access to informa-
tion about misoprostol. The third depicts issues of power
and control in cases of who is permitted to receive and
provide misoprostol for the prevention of PPH. Each of
these examples illustrates gaps in current practice, and to
demonstrate the added value of integrating a rights-based
framework into health care system development.
Unintended consequences: emphasis on facility deliveries
According to the National PPH Strategy, districts in-
volved in the scale-up should have a maternal waiting
Fig. 2 The Evolution of the Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Mozambique (Figure developed by K.
Hobday and was published in Hobday et al., 2019 [22] which is an open access journal)
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home attached to the health facility. In practice, only
half of the health facilities in the study had maternal
waiting homes, most of which were unfinished or not in
use. Even in districts where maternity homes were avail-
able at the health facility, some women explained that
due to a lack of transportation, money, child care and
support from their husband they felt they had no choice
but to wait until labour had started before trying to
reach the health facility:
Usually even the women realizing the expected date
of delivery will not go to the health unit for fear of
the long waiting time and therefore, do not want to
leave the smaller children alone at home. Men are
not staying very long with children; others are
mothers whose husbands are working in South Africa
or are single. (TBA 13).
In some cases TBAs urged women to walk for kilo-
metres to the health facility to give birth. As a result,
women reported that they gave birth on the side of the
road which put them at risk of exposure and infection.
All of the women who took part in the FGD in Nampula
Province said that they had walked in labour to reach
the health facility. TBAs described the challenges of ac-
companying women walking to the clinic, some walking
for hours slowly and in excruciating pain. One TBA de-
scribed it as ‘crawling’ as in this quote:
You know what it means to walk for a woman with
contractions, it’s practically crawling and she says “I
hurt a lot, I can not walk” and we sensitize her to be
strong and try walking and then when I see that she
is on the edge I say, “Stop to not compromise the
well-being of the newborn” (TBA 16).
All of the women who took part in the FGD in Nam-
pula Province said that they had walked in labour to
reach the health facility. This highlights the challenge of
accessing transportation and/or money to travel to the
health facility in a timely fashion, increasing risks of giv-
ing birth outdoors, in unhygienic conditions and/or
without a SBA.
Some women and TBAs said that they feared punish-
ment from health staff for births that took place at
home. Some women were even denied access to the
newborn’s immunization cards or were charged a fee to
obtain them:
We tend to be afraid to leave the woman without
help because… to get a record [birth registration rec-
ord], it gets complicated, as if we midwives [TBAs]
we were encouraging them not to come to the hos-
pital to give birth… They suffer because they are not
given the files because they gave birth outside the
maternity ward (TBA 18).
Women in one of the provinces who used misoprostol
and gave birth in the community revealed that they had
all bought the newborn’s immunization cards at varying
costs (50–100 meticais equivalent to .80–1.60 USD in
2018). One woman said, “I paid 100 meticais. That does
not have a fixed price ... they decide the amount they
want to charge ... is this a legal procedure?” (Woman
who used misoprostol, Nampula).
While many women stated that they preferred to give
birth at a health facility, some TBAs and women re-
ported that the fear of being reprimanded and denied
the newborn’s consultation card by health staff was the
main factor for attempting to reach the health facility,
even if labour was in progress.
Limiting the right to receive, request and provide
information about misoprostol
The second example depicts the lack of information pro-
vided to the community about the benefits of misopros-
tol, and how to access and use it. In some locations,
women said there was limited information about miso-
prostol, resulting in fear and misinformation. Women in
a focus group highlighted this concern saying:
People who have not yet taken it [misoprostol] say
they are afraid to take it because they do not know
what the reaction will be. Now we have tried to pass
on to them our experience that it is a good medicine
and that it does not harm the body, that it does not
kill, we are here alive and healthy (FGD 6, Erati,
Nampula).
Some women who had used misoprostol reported that
men in the community were suspicious of the medica-
tion and did not want their wives to use it. For example,
‘The men in the villages say that medicine [misoprostol]
is not good. They tell women not to go back and not to
take it (Woman who used misoprostol, Nampula).
Other women however said their husbands were
supportive:
They [husbands] praise [misoprostol] a lot because
they know full well that the woman who loses a lot
of blood during birth has many consequences. For
example, when she lost a lot of blood she gets to the
point of not being able to lift and carry a simple can
of water; this suffering can last about two or even
three months…It is different when the woman uses
this medicine, she gains strength and has good phys-
ical appearance (Woman who used misoprostol,
Inhambane).
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Some stakeholders believed that misoprostol for the
prevention of PPH was not yet widely known to be avail-
able amongst health staff and the community due to the
limited geographic reach of the program. One stake-
holder stated that, ‘Once more women know about the
misol [misoprostol] and understand it is their human
right to have it, they will be more demanding’ (Stake-
holder, Maputo). Many stakeholders felt that more work
was needed to further disseminate the National PPH
Policy across the country.
Effects of power and control to limit access to medication
The final example describes issues of power and control
over which women were chosen to access misoprostol in
advance at ANC appointments, and how much agency
was given to the TBAs to provide safe birth services.
The introduction of selection criteria to further control
the circulation of misoprostol meant that women who
delivered at home were excluded from receiving ad-
vanced misoprostol. Some health staff supported this de-
cision as they believed misoprostol should be carefully
controlled. For example:
People know that this [misoprostol] is for abortion. It
will be used two-fold and you need to be aware of it.
Post-partum haemorrhage is a big problem we have
to deal with but you also need to know that the
TBAs need to receive the correct training and the
APEs [CHWs] as well. Well misoprostol can be help-
ful but it can be dangerous as well (Stakeholder,
Maputo).
However, other health staff believed that the criteria
significantly reduced the number of women able to re-
ceive protection from an uterotonic. One stakeholder
felt that use of the selection criteria discriminated
against women and depended on the nurse or midwives
personal judgement of who can walk while in labour to
the health facility, stating, “Who can tell out of ten
women who will have a PPH?” (Stakeholder, Maputo).
Interviews revealed that some health staff limited their
distribution of misoprostol due to their personal values
about abortion. Some health staff limited their distribu-
tion of misoprostol due to their perceptions and biases
surrounding the potential for CHWs, TBAs and women
to misuse misoprostol intended for prevention of PPH
for abortion. They were concerned that a medication
which was previously highly restricted was now permit-
ted for distribution at antenatal care to women in ad-
vance of their labour and to TBAs. One health staff
stated:
The misoprostol was a controlled drug and is even
indicated for abortion. Because we have this on our
conscience, we keep guarding it. It is not to distribute
to any health unit or person we find looking for it
(Health staff, Inhambane).
TBAs spoke of the challenges they experienced work-
ing with the misoprostol program with limited resources.
TBAs receive chlorhexidine and misoprostol from the
district health centre or health post but do not receive
clean birth kits to help facilitate their work. TBAs wor-
ried about the risk of infection to themselves, the
women and the newborns. The majority of TBAs
expressed concern about assisting women to give birth
at home without gloves, water or soap, for instance:
It’s about the gloves, we only have them here in the
health unit, we do not have them at home. We only
use plastic [to cover their hands] and in these times
of illness we take risks during childbirth, so we are
worried (TBA 6).
In each of the three examples above, incorporating a
rights-based approach would shed light on a range of
other interventions and program improvements which
have not, to date, received attention.
Discussion
This article presents a case study of the Mozambique
MoH-led program to distribute misoprostol at the com-
munity level to prevent PPH. We applied a human
rights, health and development framework to understand
the broader contextual, policy and institutional issues
that may have influenced and impacted the misoprostol
program. Results from this study and the description of
the three examples where rights might have been in-
fringed, highlight some of the areas warranting further
attention to improve Mozambican women’s access to
misoprostol for the prevention of PPH and SRH more
generally. The broad policy objectives of the National
Health Sector Strategic Plan and National PPH Strategy
are laudable; however the reality of what occurs in prac-
tice must be urgently considered.
Similar to many low income countries, health care often
fails at the point of delivery – despite laudable policy com-
mitments [53]. The right to health is enshrined in the
many national laws and regional and international treaties
which Mozambique is party. The state has an obligation
to fulfil the rights of its citizens including to protect and
promote women’s reproductive rights [54, 55]. The hu-
man right to health is at the core of the existing National
Health Sector Strategic Plan and the development of the
National PPH Strategy was a positive step to elevating the
need to reduce PPH. However, with constrained funding
and capacity, the state in turn claims that it is unable to
uphold the right to health and its core elements including
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quality, access, availability and affordability. This is par-
ticularly true for SRH: Cook states, “where they [SRH
laws] exist, they are rarely or inadequately enforced” [56].
A rights-based approach offers a framework to ad-
vance human development through and accompanied by
the promotion and protection of human rights [18]. The
approach suggests that all programs intentionally guide
and support capacity building of duty bearers to meet
their obligations to international human rights [20]. The
foundation of the human rights-based approach is the
obligation of duty bearers, notably states but also those
providing services, to deliver rights. How could these
principles and policies practically translate into health
justice? How might we apply a human rights-based ap-
proach to the misoprostol program to improve accessi-
bility, affordability, quality and non-discrimination?
Institutions and organisations using this approach
must provide relevant and transparent information to
their beneficiaries [57]. The MoH would shift focus to
communities to provide accurate information about how
and when to use misoprostol, potential side effects and
are made aware of their SRH rights. Not all health staff
were aware of the National PPH Strategy which may
have impacted the low distribution of misoprostol in the
study locations. The application of a rights-based ap-
proach would bolster efforts to share the National PPH
Strategy with health staff and communities alike.
Health staff should facilitate active participation and
engagement of the community in all stages of the pro-
gram from design to implementation. Participation en-
sures that services are appropriate and encourages
rights-holders to exert agency to claim their rights [58].
In addition, partners can encourage the MoH as duty-
bearers to respect SRH rights. Women should be reposi-
tioned to be at the centre of women’s health program
planning, monitoring and evaluation.
The SDG goal to reduce MMR is supported by en-
couraging facility-based births with an SBA. However,
the example of strict encouragement of facility-based
birth highlighted the limited recognition of unintended
negative consequences. There is clearly a need to con-
sider the challenges women experience in reaching facil-
ities in the presence of limited resources or a lack of
transportation. Strategies directed at increasing facility
births are expected in all maternal health programs;
combining this with protection and care of individual
women who cannot for social and economic constraints
access a health facility is not disingenuous or sending
“mixed messages”, but rather upholding women’s SRH
rights as the country invests in infrastructure, builds
trust and improves the quality of services.
Evidence of giving birth while walking to the facility vio-
lates women’s rights to quality health care and privacy and
ignores her safety and dignity. Improving access to
emergency transportation to health facilities in remote lo-
cations is central to improving maternal health outcomes.
The MoH may consider global best practices to secure
funding and systems to increase the number of ambu-
lances, including tricycle or motorcycle ambulances; in-
creasing outreach services; and work with communities to
develop community savings schemes or other forms of
pooled funds to assure emergency transportation.
Discrimination, punishment and extortion for women
who are unable to reach the health facility to deliver vio-
lates the right to birth registration. This is - a fundamen-
tal human right stated in article 24, paragraph 2 of the
International Covenant on Civil and Political Rights and
article 7 of the Convention on the Rights of the Child
[59]. Without the newborn’s immunization cards, fam-
ilies are unable to register the birth of their child if born
outside of a hospital. This institutional barrier violates
both the mother’s and child’s rights and reflects major
imbalances in power and control. A similar phenomenon
was reported in Sierra Leone, where patients were often
required to pay for health services, including their child’s
immunization record, despite stipulation that healthcare
is free [60]. Women disproportionately suffer the conse-
quences of additional out of pocket expenditures [57].
Increasing national expenditure on health and ensuring
health staff are fairly compensated and have adequate re-
sources to conduct their work would likely reduce cor-
ruption, in combination with efforts to bolster social
accountability. The MoH can reiterate with health staff
that their duty is to issue consultation/birth registration
cards to all newborns, regardless of location of birth; the
public in turn must know it is their right to register their
babies without paying bribes, and have recourse to com-
plaint systems where their rights are not met.
Examples of access to limited information highlight the
need for proactive efforts to ensure information about
SRH services, facilities and how to access them. The right
to receive, request and provide information is protected
by all human rights conventions [56]. The lack of informa-
tion may have influenced men’s negative perceptions
about misoprostol, leading to reduced uptake by women.
Feinglass, Gomess & Maru have worked to support a cadre
of grassroots health advocates in Mozambique that blend
legal empowerment and social accountability: they raise
awareness on health policy and people’s rights, help clients
seek justice for their complaints, and facilitate dialogues be-
tween communities and health staff [61]. Their positive ex-
periences addressing over a thousand grievances across 27
health facilities suggests that when people know their rights
and are equipped to exercise them, the health system im-
proves. Women and communities first need to know of the
purpose of misoprostol and where it is available.
The final example depicted the dynamics of power and
control between who was permitted to receive misoprostol.
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This revealed that the application of the selection criteria
limited the number of women targeted to receive advanced
distribution of misoprostol for the prevention of PPH.
MNCH nurses restricted access by strictly applying the cri-
teria and in some cases using their personal judgement and
biases to decide who should receive misoprostol. The right
to essential medicines, as defined under the WHO Action
Programme on Essential Drugs, is also a core obligation of
the state [19]. The Mozambican government is obliged to
uphold this right and ensure all citizens have access to es-
sential medicines, including misoprostol. Since 2002, nu-
merous studies have been undertaken on the feasibility of
distributing misoprostol for the prevention of PPH at the
community level. The studies were conducted in low in-
come countries and revealed that the vast majority of
women were able to correctly administer misoprostol
themselves or with CHW assistance [62]. It will take time
to shift the culture to trust CHWs to distribute misoprostol
and women themselves to safely use it. A rights-based ap-
proach will re-frame the issue to reinforce that women have
a right to access this life-saving medication – whether this
is through CHWs, TBAs or advance distribution to the
women themselves.
Limitations
The research was undertaken in two provinces of
Mozambique and cannot be widely generalised. However,
the case study highlighted issues that warrant systematic
rights-based responses; these are likely to be applicable
elsewhere. Secondary data sources formed the basis of the
analysis on human rights and development; further pri-
mary research on these issues would be of value.
Conclusion
The human rights, health and development framework re-
vealed structural and institutional challenges which exac-
erbated gaps to the misoprostol program. Mozambique
has a strong foundation for supporting human rights, in-
cluding the right to sexual and reproductive health. The
MoH has prioritized the reduction of MMR within the five
key priorities of the National Health Sector Strategy
2014–2019. In addition, the 2014 abortion reform was a
positive step towards improving access to sexual and re-
productive health rights. However, Mozambique has not
ratified the ICESCR which is the most important Coven-
ant for the right to health. Human rights are not fully up-
held by the state and more importantly many citizens are
unaware of their rights, including their right to SRH.
Through the misoprostol program, Mozambique has
made strides in improving uterotonic coverage to women
who are unable to reach a health facility to give birth. Ap-
plying a rights- based approach to the implementation of
the misoprostol program combined with improvements to
ensure health services are accessible, available, affordable
and of high quality are needed to improve maternal health
outcomes in the country.
From our knowledge, this is the first application of the
health, human rights and development framework to a
specific case study. This study adds to the literature and
evidence base reaffirming the strong interconnection be-
tween health, human rights and development and the
value of integrating their underlying concepts to ensure
policies are not applied blindly and that the right-to-
health is at the forefront of health services delivery.
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